Biologic treatment outcomes in refractory bullous pemphigoid: An evidence-based review

• Abrahim Abduelmula, BScN,
• Asfandyar Mufti, MD,
• Derrick H.Y. Chong, BSc,
• Siddhartha Sood, HBSc,
• Vimal H. Prajapati, MD,
• Jensen Yeung, MD

Affiliations

Abrahim Abduelmula, BScN

Faculty of Medicine, University of Western Ontario, London, Ontario, Canada

Asfandyar Mufti, MD

Division of Dermatology, Department of Medicine, University of Toronto, Ontario, Canada

Derrick H.Y. Chong, BSc

Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada

Siddhartha Sood, HBSc

Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada

Vimal H. Prajapati, MD

Division of Dermatology, Department of Medicine, University of Calgary, Calgary, Alberta, Canada; Dermatology Research Institute, Calgary, Alberta, Canada; Skin Health & Wellness Centre, Calgary, Alberta, Canada; Probity Medical Research, Calgary, Alberta, Canada; Section of Community Pediatrics, Department of Pediatrics, University of Calgary, Calgary, Alberta, Canada; Section of Pediatric Rheumatology, Department of Pediatrics, University of Calgary, Calgary, Alberta, Canada

Jensen Yeung, MD

Division of Dermatology, Department of Medicine, University of Toronto, Ontario, Canada; Women's College Research Institute, Women's College Hospital, Toronto, Ontario, Canada; Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada; Probity Medical Research, Waterloo, Ontario, Canada; Correspondence to: Jensen Yeung, MD, Division of Dermatology, Women’s College Hospital, 76 Grenville St, 5th Floor, Toronto, Ontario, M5S 1B2, Canada